2.57 USD
+0.1 (+4.05%)
Taking everything into account, BMRA scores 2 out of 10 in our fundamental rating. BMRA was compared to 186 industry peers in the Health Care Equipment & Supplies industry. While BMRA seems to be doing ok healthwise, there are quite some concerns on its profitability. BMRA has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- BMRA had negative earnings in the past year.
- BMRA had a negative operating cash flow in the past year.
- BMRA had negative earnings in each of the past 5 years.
- BMRA had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- BMRA has a Return On Assets of -53.33%. This is in the lower half of the industry: BMRA underperforms 67.20% of its industry peers.
- BMRA has a Return On Equity of -70.90%. This is comparable to the rest of the industry: BMRA outperforms 44.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -53.33% | ||
| ROE | -70.9% | ||
| ROIC | N/A |
ROA(3y)-65.89%
ROA(5y)-60.11%
ROE(3y)-90.92%
ROE(5y)-81.57%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a Gross Margin value of 13.02%, BMRA is not doing good in the industry: 81.18% of the companies in the same industry are doing better.
- BMRA's Gross Margin has declined in the last couple of years.
- The Profit Margin and Operating Margin are not available for BMRA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 13.02% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.95%
GM growth 5Y-18.46%
2. Health
2.1 Basic Checks
- BMRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- BMRA has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for BMRA has been increased compared to 5 years ago.
- BMRA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- BMRA has an Altman-Z score of -9.09. This is a bad value and indicates that BMRA is not financially healthy and even has some risk of bankruptcy.
- BMRA has a Altman-Z score of -9.09. This is in the lower half of the industry: BMRA underperforms 78.49% of its industry peers.
- There is no outstanding debt for BMRA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -9.09 |
ROIC/WACCN/A
WACC10.02%
2.3 Liquidity
- A Current Ratio of 3.48 indicates that BMRA has no problem at all paying its short term obligations.
- With a decent Current ratio value of 3.48, BMRA is doing good in the industry, outperforming 61.83% of the companies in the same industry.
- A Quick Ratio of 2.61 indicates that BMRA has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 2.61, BMRA is in the better half of the industry, outperforming 61.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.48 | ||
| Quick Ratio | 2.61 |
3. Growth
3.1 Past
- BMRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.18%, which is quite impressive.
- BMRA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.31%.
- Measured over the past years, BMRA shows a decrease in Revenue. The Revenue has been decreasing by -4.51% on average per year.
EPS 1Y (TTM)44.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.13%
Revenue 1Y (TTM)-11.31%
Revenue growth 3Y-34.47%
Revenue growth 5Y-4.51%
Sales Q2Q%-23.63%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for BMRA. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for BMRA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BIOMERICA INC / BMRA FAQ
Can you provide the ChartMill fundamental rating for BIOMERICA INC?
ChartMill assigns a fundamental rating of 2 / 10 to BMRA.
What is the valuation status for BMRA stock?
ChartMill assigns a valuation rating of 0 / 10 to BIOMERICA INC (BMRA). This can be considered as Overvalued.
Can you provide the profitability details for BIOMERICA INC?
BIOMERICA INC (BMRA) has a profitability rating of 0 / 10.
Can you provide the financial health for BMRA stock?
The financial health rating of BIOMERICA INC (BMRA) is 6 / 10.